Pri-Med Podcasts

HIV 101: Improving Access to Screening and Prevention Through a Status-Neutral Approach

Credits: 0.75 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/hiv-101-improving-access-to-screening-and-prevention 
Overview: In the first episode of the three-part HIV 101 series, get a baseline understanding of HIV care today and learn just how simple HIV treatment is. Dr. Simmons and his guest cover topics such as syndemics, a status-neutral approach to screening, Undetectable = Untransmittable, and treatment as prevention. You will also learn about the critical role of primary care clinicians in improving access to care and reducing HIV-related stigma. 

Beta-Blockers Post-Myocardial Infarction: Are They Still Needed? - Frankly Speaking Ep 371

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-371
Overview: Beta-blockers have traditionally been used indefinitely after a myocardial infarction (MI), but this is now only recommended for a subset of patients. Listen in as faculty review new recommendations for managing patients with chronic cardiac disease, including how to determine which patients are good candidates for beta-blocker therapy and for how long.
Episode resource links:
Virani SS, Newby LK, Arnold SV, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines [published correction appears in Circulation. 2023 Sep 26;148(13):e148] [published correction appears in Circulation. 2023 Dec 5;148(23):e186]. Circulation. 2023;148(9):e9-e119. 
Joo SJ. Beta-blocker therapy in patients with acute myocardial infarction: not all patients need it. Acute Crit Care. 2023;38(3):251-260. 
Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Richard Onorato

Low Back Pain—More Evidence for the Effectiveness of Nonnarcotic Modalities - Frankly Speaking Ep 370

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-370
Overview: Low back pain is one of the most common symptoms presenting in primary care. Listen in as we analyze the results of a recent systematic review supporting the use of a variety of effective nonnarcotic treatments for this condition. Gain evidence-based insights to help you choose the most informed option for managing low back pain.
Episode resource links:
Gianola S, Bargeri S, Del Castillo G, et al. Br J Sports Med 2022;56:41–50. doi.org/ 10. 1136/ bjsports- 2020- 103596).
Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato

Be a Flamingo: 1-Legged Stance Test Predicts Risks - Frankly Speaking Ep 369

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-369
Overview: Uncover a simple, 10-second intervention—the 1-legged stance test—for predicting the risk of falling in adults. Join us as we discuss how this swift assessment can help identify patients who are prone to falls, fractures, and increased mortality. This episode brings you a practical tool to enhance patient assessments and tailor interventions, contributing to a more proactive and personalized approach to care.
Episode resource links:
JAMA. 2023;329(18):1605-1607. doi:10.1001/jama.2023.3054
Br J Sports Med. 2022;56:975–980.
Pharmacoepidemiol Drug Saf. 2021 Aug;30(8):1049-1056. doi: 10.1002/pds.5201
PLoS Med 18(11): e1003821. https://doi.org/10.1371/journal.pmed.1003821
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato

Data-Driven Perspectives on Prescriptive Authority and the Quality Quandary - Frankly Speaking Ep 368

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-368
Overview: In this insightful episode, we explore compelling data comparing inappropriate prescribing practices among physicians and nonphysician prescribers. This discussion covers the nuances and restrictive scope of prescribing authority and aims to take an evidence-based approach to encouraging collaboration between clinicians and expanding patients’ access to care.
Episode resource links:
Huynh, J., Alim, S. A., Chan, D. C., & Studdert, D. M. (2023). Inappropriate Prescribing to Older Patients by Nurse Practitioners and Primary Care Physicians. Annals of internal medicine, 176(11), 1448–1455. https://doi.org/10.7326/M23-0827
American Association of Nurse Practitioners https://www.aanp.org/
American Academy of Physician Associates https://www.aapa.org/
Jiao, S., Murimi, I. B., Stafford, R. S., Mojtabai, R., & Alexander, G. C. (2018). Quality of Prescribing by Physicians, Nurse Practitioners, and Physician Assistants in the United States. Pharmacotherapy, 38(4), 417–427. https://doi.org/10.1002/phar.2095
2023 Beers Criteria American Geriatrics Society: Free to read https://agsjournals.onlinelibrary.wiley.com/doi/epdf/10.1111/jgs.18372
Guest: Jill M. Terrien PhD, ANP-BC  Music Credit: Richard Onorato

The Portfolio Diet—Another Approach to Eating Healthy? - Frankly Speaking Ep 367

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-367
Overview: Join us for a look at the Portfolio Diet, a plant-based approach with potential to improve cardiovascular outcomes. We’ll take you through the details of this regimen and what the evidence says about its effect on the risks of cardiovascular diseases. Stay informed on the latest research and feel prepared to answer your patients’ questions about the Portfolio Diet.
Episode resource links:
Circulation. 2023;148:00–00. DOI: 10.1161/CIRCULATIONAHA.123.065551
Guest: Robert A. Baldor, MD, FAAFP Music Credit: Richard Onorato

Synching Up: Time-Restricted Eating for T2DM Management - Frankly Speaking Ep 366

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-366
Overview: Join us as we explore the nuances of healthy eating patterns, distinguishing between time-restricted and calorie-restricted approaches. We also review a randomized controlled trial that found time-restricted eating for people with type 2 diabetes mellitus (T2DM) can benefit HbA1c levels and weight reduction. Gain insights to elevate patient care in understanding and implementing these impactful dietary strategies.
Episode resource links:
Pavlou V, Cienfuegos S, Lin S, et al. Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes: A Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2339337. doi:10.1001/jamanetworkopen.2023.39337
Jefcoate PW, Robertson MD, Ogden J, Johnston JD. Exploring Rates of Adherence and Barriers to Time-Restricted Eating. Nutrients. 2023 May 16;15(10):2336. doi: 10.3390/nu15102336. PMID: 37242218; PMCID: PMC10223820.
Guest: Jillian Joseph, MPAS, PA-C Music Credit: Richard Onorato

Your Gut Doesn’t Have to Be Irritated: Treatment Options for IBS - Frankly Speaking Ep 365

Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-365
Overview: The chronic nature of irritable bowel syndrome (IBS) necessitates persistence when trialing treatment options. After reviewing key identifiers of IBS, we discuss a second-line treatment’s efficacy in reducing symptoms and improving quality of life for patients with continued IBS symptoms. Tune in for valuable insights to make informed recommendations for your patients.
Episode resource links:
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial - PubMed (nih.gov)
https://www.aafp.org/pubs/afp/issues/2005/1215/p2501.html
Guest: Mariyan L. Montaque, DNP, FNP-BC Music Credit: Richard Onorato

Mind Over Memory: Strategies for Increasing Early Identification of Alzheimer Disease from a Dementia Specialist

Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.48 AANP, including 0 AANP Pharm CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/mind-over-memory-1 Overview: In this podcast, expert faculty bring you insights from the evolving area of Alzheimer disease diagnosis, including strategies for improving identification of cognitive decline and incorporating evidence-based tools in screening. Discover the impact of advanced neuroimaging and fluid markers, empowered by recent FDA approvals of anti-amyloid therapies. Come away with actionable knowledge to boost your role in cognitive health.  Guest: Jessica L. Zwerling, MD, MS 

Mind Over Memory: New Treatment Options for Alzheimer Disease

Credits: 0.50 AMA PRA Category 1 Credits™, 0.50 ABIM MOC or 0.48 AANP, including 0.48 AANP Pharm CME/CE Information and Claim Credit: https://www.pri-med.com/online-cme-ce/podcast/mind-over-memory-2 Overview: Embark on a captivating journey with our distinguished neurology faculty as they delve into the revolutionary world of FDA-approved monoclonal antibody therapies targeting β-amyloid in the treatment of Alzheimer disease (AD). Uncover clinical efficacy, safety nuances, and differences between these newer disease-modifying agents compared to older medications used for AD. Gain insights on identifying which patients are most likely to benefit from these cutting-edge agents and who warrants referral to a dementia specialist. Elevate your understanding of AD treatment and join the forefront of medical innovation.  Guest: Daniel Press, MD